Evidence map›Paper›PMID 41495349›Full record

ArticleScientific reports2026

sc-eQTL unveil immunogenetic architecture of polycystic ovary syndrome.

Xiaoqian Xu, Yuzhou Bao, Qi Zhang, Lixia Wang, Hao Wang

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Xiaoqian Xu *Department of Obstetrics, Shenzhen University General Hospital, Shenzhen, China.
Yuzhou Bao *Department of Hematology, The First Affiliated Hospital, Institute of Hematology, School of Medicine, Xiamen University, Xiamen, China.
Qi Zhang *School of Medicine, Shenzhen University, Shenzhen, China.
Lixia WangDepartment of Obstetrics, Shenzhen University General Hospital, Shenzhen, China. wanglixia691130@163.com.
Hao WangDepartment of Obstetrics and Gynaecology, Shenzhen Baoan Women's and Children's Hospital, Maternal Fetal Medicine Institute, Shenzhen University, Shenzhen, China. haowang0806@gmail.com.

Funding

Shenzhen Nanshan District Technology R&D and Creative Design Project Sub-funding No. NS2023130
6 · The paper itself

Abstract

Polycystic ovary syndrome (PCOS) is a complex endocrine disorder characterized by metabolic, inflammatory, and reproductive dysfunction. We integrated genome-wide association study (GWAS) data, and single-cell expression quantitative trait loci (sc-eQTL) across various immune cells to elucidate the genetic and immune mechanisms underlying PCOS at the cellular level. Finally, we identified 19 risk loci for PCOS, prioritizing 16 candidate causal genes, approximately 30% of these genes are immune-related. Pathway analysis revealed 15 PCOS-associated signaling pathways, spanning hormonal regulation and immune function, notably T cell-mediated responses. Single-cell RNA sequencing analysis implicated NK cells, CD8 T cells, and CD4 T cells play a crucial role in PCOS pathogenesis, with the highest trait-relevant scores. sc-eQTL colocalization analysis identified IRF1 and MAPRE1 as causal genes with regulatory effects in specific T cell subsets and NK cells, which were obscured by bulk eQTL analysis. Moreover, MAPRE1 showing a discordant effect in NK cells, suggesting immune dysregulation. Our findings underscore the pivotal roles of metabolic and immune-related genes in PCOS and the importance of immune cell-specific mechanisms, enhancing our understanding of its pathophysiology and potential therapeutic targets.

Indexed as

Polycystic Ovary SyndromeQuantitative Trait LociCD4-Positive T-LymphocytesFemaleGenetic Predisposition to DiseaseGenome-Wide Association StudyHumansKiller Cells, NaturalPolymorphism, Single NucleotideSingle-Cell Analysis

Identifiers

PMID41495349
PMCPMC12864734

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.